Combination therapy with an endothelin-1 receptor antagonist (bosentan) and a phosphodiesterase V inhibitor (sildenafil) for the management of severe digital ulcerations in systemic sclerosis.

Details

Language :

English

ISSN :

01909622

Volume :

65

Issue :

3

Database :

Supplemental Index

Journal :

Journal of the American Academy of Dermatology

Publication Type :

Academic Journal

Accession number :

64868880

Full Text :

https://doi.org/10.1016/j.jaad.2011.04.029